Clinical Trial Update: Transplantation of Fecal Microbiota for Clostridium Difficile Infection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating fecal microbiota transplantation for Clostridioides difficile infection; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Clostridium Difficile Infection | Phase 3 | Status: UNKNOWN